A study in Budapest, Hungary found that intranasal oxytocin may help improve social functioning, quality of life, and overall symptoms in adults with autism spectrum disorder (ASD). The research showed that adults with ASD often struggle with social interactions and loneliness, leading to anxiety and social isolation. Participants who received oxytocin showed improvement in various assessments, but more research is needed to draw definitive conclusions. The study had limitations, including differences in baseline oxytocin levels and treatment doses. While the findings are promising, the clinical significance of using oxytocin for ASD remains controversial. No financial disclosures were reported by the investigators.
Source link